您当前的位置:
首页 >
文章列表页 >
Therapeutic genome editing of an aberrant splice site in β-thalassemia by CRISPR/Cas9 with multiple sgRNAs
Short communication | 更新时间:2024-02-04
    • Therapeutic genome editing of an aberrant splice site in β-thalassemia by CRISPR/Cas9 with multiple sgRNAs

    • Genes & Diseases   Vol. 1, Issue 1, Pages: 15-18(2024)
    • 作者机构:

      1. Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University,Shanghai,China,200241

      2. BRL Medicine Inc.,Shanghai,China,201108

      3. Department of Hematology, Qilu Hospital, Cheeloo College of Medicine, Shandong University,Shandong,Jinan,China,250012

      4. Department of Hematology, The First Affiliated Hospital of Guangxi Medical University,Guangxi,Nanning,China,530000

      5. Department of Neurology, The First Affiliated Hospital, Zhejiang University School of Medicine,Zhejiang,Hangzhou,China,310003

      6. Department of Obstetrics and Gynecology, The First Affiliated Hospital of Anhui Medical University,Anhui,Hefei,China,230022

      7. NHC Key Laboratory of Study on Abnormal Gametes and Reproductive Tract (Anhui Medical University),Anhui,Hefei,China,230032

    • DOI:10.1016/j.gendis.2023.01.010    

      CLC:
    • Published:2024,

      Published Online:1 January 2024,

    扫 描 看 全 文

  • Fei Yang, Shuqian Xu, Chao Huang, et al. Therapeutic genome editing of an aberrant splice site in β-thalassemia by CRISPR/Cas9 with multiple sgRNAs. [J]. Genes & Diseases 1(1):15-18(2024) DOI: 10.1016/j.gendis.2023.01.010.

  •  
  •  
查看原文

0

Views

0

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

No data

Related Author

No data

Related Institution

No data
0